Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease-Reference-Cited by-同舟云学术

Nanoparticles for oral delivery: targeted therapy for inflammatory bowel disease

Published:2022 Issue:31 Volume:10 Page:5853-5872
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Li De-feng¹,Yang Mei-feng²,Xu Hao-ming³,Zhu Min-zheng³^ORCID,Zhang Yuan⁴,Tian Cheng-mei⁵,Nie Yu-qiang³,Wang Jian-yao⁶,Liang Yu-jie⁷^ORCID,Yao Jun¹,Wang Li-sheng¹^ORCID

Affiliation:

1. Department of Gastroenterology, Shenzhen People's Hospital (the Second Clinical Medical College, Jinan University, the First Affiliated Hospital, Southern University of Science and Technology), No. 1017, Dongmen North Road, Luohu District, Shenzhen 518020, Guangdong, China

2. Department of Hematology, Yantian District People's Hospital, Shenzhen 518020, Guangdong, China

3. Department of Gastroenterology and Hepatology, Guangzhou Digestive Disease Center, Guangzhou First People's Hospital, School of Medicine, South China University of Technology, Guangzhou 510030, China

4. Department of Medical Administration, Huizhou Institute of Occupational Diseases Control and Prevention, Huizhou 516000, Guangdong, China

5. Department of Emergency, Shenzhen People's Hospital (the Second Clinical Medical College, Jinan University, the First Affiliated Hospital, Southern University of Science and Technology), Shenzhen 518020, Guangdong, China

6. Department of General Surgery, Shenzhen Children's Hospital, No. 7019, Yitian Road, Futian District, Shenzhen 518026, Guangdong, China

7. Shenzhen Kangning Hospital, No. 1080, Cuizu Road, Luohu District, Shenzhen 518020, Guangdong, China

Abstract

As a group of chronic and idiopathic gastrointestinal (GI) disorders, inflammatory bowel disease (IBD) is characterized by recurrent intestinal mucosal inflammation.

Funder

Natural Science Foundation of Guangdong Province

National Natural Science Foundation of China

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2022/TB/D2TB01190E

Reference214 articles.

1. Pathophysiology of Inflammatory Bowel Diseases

2. Update on the epidemiology of inflammatory bowel disease in Asia: where are we now?

3. New Insights and Advances in Pathogenesis and Treatment of Very Early Onset Inflammatory Bowel Disease

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering the cofactor binding site of 7α-hydroxysteroid dehydrogenase for improvement of catalytic activity, thermostability, and alteration of substrate preference;International Journal of Biological Macromolecules;2024-02

2. Iron oxide nanoparticles for inflammatory bowel disease: Recent advances in diagnosis and targeted drug therapy;Applied Surface Science Advances;2024-02

3. Responsively Degradable Nanoarmor‐Assisted Super Resistance and Stable Colonization of Probiotics for Enhanced Inflammation‐Targeted Delivery;Advanced Materials;2024-01-26

4. Orally-administered nanomedicine systems targeting colon inflammation for the treatment of inflammatory bowel disease: latest advances;Journal of Materials Chemistry B;2024

5. Advancements in hydrogel-based drug delivery systems for the treatment of inflammatory bowel disease: a review;Biomaterials Science;2024